November 03, 2025

Gingival Swelling and Recurrent Epistaxis: What’s Your Diagnosis?

A 69-year-old woman developed progressive gingival swelling, weight loss, and recurrent nasal bleeding. Imaging showed pulmonary nodules and biopsy confirmed necrotizing vasculitis with multinucleated giant cells. What’s your diagnosis?

Conexiant

October 31, 2025

Single-Injection Omvoh Option Simplifies Ulcerative Colitis Care

The FDA approved Eli Lilly’s interleukin-23p19 antagonist Omvoh (mirikizumab-mrkz) as a once-monthly single-injection maintenance option for adults with moderately to severely active ulcerative colitis.

Conexiant

October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant

October 29, 2025

Can SGLT-2 Inhibitors Shield Against Autoimmune Disease?

Researchers found sodium-glucose cotransporter-2 inhibitors lowered autoimmune rheumatic disease risk by 11% in adults with type 2 diabetes.

Conexiant

October 29, 2025

Unstable Sitting Replicated Real-World Lumbar Posture

Unstable sitting mirrors natural lumbar alignment tracked over 2 days.

Conexiant

October 24, 2025

A New Approach to Lowering Cardiovascular Risk?

Researchers evaluated obicetrapib’s effects on lipid levels and cardiovascular outcomes.

Conexiant

October 22, 2025

Medical Oddities: Oxygen Via Rectum?

Oxygen from below, coffee for gout, and hugs with hidden motives—just another week.

Conexiant

October 21, 2025

Mediterranean Metabolite Signature Tied to Lower RA, Study

66-metabolite signature explains 22.4% of the Mediterranean diet–RA relationship.

Conexiant

October 20, 2025

Obinutuzumab Wins FDA Nod for Lupus Nephritis

Roche's anti-CD20 antibody improved renal response and allowed for lower corticosteroid use in the phase III REGENCY trial, offering a twice-yearly maintenance option after initial dosing.

Conexiant